1. Entry
     Clinical Genomic Statement Genetic Variation (2.16.840.1.113883.10.20.20.2.1)
    1. Entry
       Interpretive Phenotype Genetic Variation (2.16.840.1.113883.10.20.20.2.5.3)
    2. Entry
       Interpretive Phenotype Pharmacogenomic Drug Efficacy (2.16.840.1.113883.10.20.20.2.5.4.1)
    3. Entry
       Interpretive Phenotype Pharmacogenomic Drug Metabolism (2.16.840.1.113883.10.20.20.2.5.4.2)
    4. Entry
       Genetic Variation Associated Observation Amino Acid Change Type (2.16.840.1.113883.10.20.20.2.1.1.1)
    5. Entry
       Genetic Variation Associated Observation D N A Change Type (2.16.840.1.113883.10.20.20.2.1.2.1)
    6. Entry
       Genetic Variation Associated Observation D N A Region Name (2.16.840.1.113883.10.20.20.2.1.3)
    7. Entry
       Genetic Variation Associated Observation Zygosity (2.16.840.1.113883.10.20.20.2.1.4)
    8. Entry
       Genetic Variation Associated Observation D N A Change Type (2.16.840.1.113883.10.20.20.2.1.2.1)
    9. Entry
       Genetic Variation Associated Observation Amino Acid Change Type (2.16.840.1.113883.10.20.20.2.1.1.1)
    10. Entry
       Genetic Variation Associated Observation Gene Identifier (2.16.840.1.113883.10.20.20.2.1.5)
    11. Entry
       Genetic Variation Associated Observation Transcript Reference Sequence Identifier (2.16.840.1.113883.10.20.20.2.1.6)
    12. Entry
       Genetic Variation Associated Observation D N A Sequence Variation Identifier (2.16.840.1.113883.10.20.20.2.1.7)
    13. Entry
       Genetic Variation Associated Observation Genomic Reference Sequence Identifier (2.16.840.1.113883.10.20.20.2.1.8)